Axura 10 mg film-coated tablets

Summary of Product Characteristics (EMEA, PDF Download)

Vaisto informacinis lapelis (pacientams)
Vaisto charakteristikų santrauka (gydytojams)
Name of the medicinal product
Qualitative and quantitative composition
Pharmaceutical form
Clinical particulars
Pharmacological properties
Pharmaceuticals particulars
Marketing authorisation holder
Marketing authorisation number
Date of first authorisation number

Axura 10 mg/g oral drops, solution

©2004 Merz | Privacy Policy | Terms of Use | Imprint

Last update: 23 Jun 2004, 11:59 AM

produced by GPM mbH

^| Merz website

^| News ^| Axura ^| Alzheimer's ^| Caregivers ^| Service ^| FAQ ^| Kontaktai

Service

Kontaktai

> axura.info > Axura® > Product Characteristics > Axura 10 mg film-coated tablets

Axura®

Brief profile

Product Characteristics

Mode of Action

Preclinical Data

Clinical Studies

Tolerability

Dosage

Produkto charakteristika

Slide Kit

Clinical Studies of memantine

AXURA®

Product monograph, available as download

Namenda®

Memantine is available in the USA as NAMENDA

If you can read this text, your browser browser does not the support the Web standard Cascading Style Sheets (C S S) for graphic display. We use C S S for page formatting, please don’t wonder if the pages display somewhat screwed lacking C S S.

axura.info. Axura 10 mg film-coated tablets.
Retrieved 05 Aug 2004, 07:36 AM from Merz.com Web site: http://www.axura.info/axura/characteristics/film-coated_tablets/

Copyright © 2004 Merz. All rights reserved.